<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Cardiol</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Cardiology</journal-title></journal-title-group><issn pub-type="ppub">2380-6583</issn><issn pub-type="epub">2380-6591</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11270247</article-id><article-id pub-id-type="pmcid-ver">PMC11270247.1</article-id><article-id pub-id-type="pmcaid">11270247</article-id><article-id pub-id-type="pmcaiid">11270247</article-id><article-id pub-id-type="pmid">39046724</article-id><article-id pub-id-type="doi">10.1001/jamacardio.2024.2019</article-id><article-id pub-id-type="publisher-id">hoi240040</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group><subj-group subj-group-type="allowCommenting"><subject>Comments</subject></subj-group></article-categories><title-group><article-title>Contribution of Clinical Trial Event Data by Data Source</article-title><subtitle>A Prespecified Analysis of the ADAPTABLE Randomized Clinical Trial</subtitle><alt-title alt-title-type="headline">Contribution of Clinical Trial Event Data by Data Source</alt-title><alt-title alt-title-type="running-head">Contribution of Clinical Trial Event Data by Data Source</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Rymer</surname><given-names initials="JA">Jennifer A.</given-names></name><degrees>MD</degrees><degrees>MBA</degrees><degrees>MHS</degrees><xref rid="hoi240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mulder</surname><given-names initials="H">Hillary</given-names></name><degrees>MS</degrees><xref rid="hoi240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wruck</surname><given-names initials="LM">Lisa M.</given-names></name><degrees>PhD</degrees><xref rid="hoi240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mu&#241;oz</surname><given-names initials="D">Daniel</given-names></name><degrees>MD</degrees><degrees>MPA</degrees><xref rid="hoi240040aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kripalani</surname><given-names initials="S">Sunil</given-names></name><degrees>MD</degrees><degrees>MSc</degrees><xref rid="hoi240040aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Effron</surname><given-names initials="MB">Mark B.</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gupta</surname><given-names initials="K">Kamal</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Handberg</surname><given-names initials="E">Eileen</given-names></name><degrees>PhD</degrees><xref rid="hoi240040aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jain</surname><given-names initials="S">Sandeep</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Girotra</surname><given-names initials="S">Saket</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Whittle</surname><given-names initials="J">Jeffrey</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="hoi240040aff8" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hess</surname><given-names initials="R">Rachel</given-names></name><degrees>MD</degrees><degrees>MS</degrees><xref rid="hoi240040aff9" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Benziger</surname><given-names initials="CP">Catherine P.</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="hoi240040aff10" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Knowlton</surname><given-names initials="KU">Kirk U.</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff11" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Curtis</surname><given-names initials="LH">Lesley H.</given-names></name><degrees>PhD</degrees><xref rid="hoi240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Roe</surname><given-names initials="MT">Matthew T.</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hammill</surname><given-names initials="BG">Bradley G.</given-names></name><degrees>DrPH</degrees><xref rid="hoi240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rothman</surname><given-names initials="RL">Russell L.</given-names></name><degrees>MD</degrees><degrees>MPP</degrees><xref rid="hoi240040aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Harrington</surname><given-names initials="R">Robert</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff12" ref-type="aff">
<sup>12</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hernandez</surname><given-names initials="A">Adrian</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jones</surname><given-names initials="WS">W. Schuyler</given-names></name><degrees>MD</degrees><xref rid="hoi240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="hoi240040aff1"><label>1</label>Duke Clinical Research Institute, Durham, North Carolina</aff><aff id="hoi240040aff2"><label>2</label>Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="hoi240040aff3"><label>3</label>John Ochsner Heart and Vascular Institute, University of Queensland&#8211;Ochsner Clinical School, New Orleans, Louisiana</aff><aff id="hoi240040aff4"><label>4</label>University of Kansas School of Medicine, Kansas City</aff><aff id="hoi240040aff5"><label>5</label>University of Florida, Gainesville</aff><aff id="hoi240040aff6"><label>6</label>University of Pittsburgh, Pittsburgh, Pennsylvania</aff><aff id="hoi240040aff7"><label>7</label>University of Iowa, Iowa City</aff><aff id="hoi240040aff8"><label>8</label>Medical College of Wisconsin, Milwaukee</aff><aff id="hoi240040aff9"><label>9</label>University of Utah, Salt Lake City</aff><aff id="hoi240040aff10"><label>10</label>Essentia Health, Duluth, Minnesota</aff><aff id="hoi240040aff11"><label>11</label>Intermountain Health, Salt Lake City, Utah</aff><aff id="hoi240040aff12"><label>12</label>Stanford University, Stanford, California</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> May 16, 2024.</p><p content-type="published-online"><bold>Published Online:</bold> July 24, 2024. doi:<uri content-type="doi">10.1001/jamacardio.2024.2019</uri></p><corresp id="hoi240040cor1"><bold>Corresponding Author:</bold> Jennifer A. Rymer, MD, MBA, MHS, Duke Clinical Research Institute, 300 W Morgan St, Durham, NC 27701 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jennifer.rymer@duke.edu">jennifer.rymer@duke.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Rymer had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Rymer, Mulder, Mu&#241;oz, Kripalani, Benziger, Knowlton, Curtis, Roe, Rothman, Harrington, Hernandez, Jones.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> Rymer, Mulder, Wruck, Mu&#241;oz, Effron, Gupta, Handberg, Jain, Girotra, Whittle, Hess, Benziger, Knowlton, Hammill, Rothman, Harrington, Hernandez, Jones.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Rymer, Benziger, Knowlton.</p><p><italic toggle="yes">Critical review of the manuscript for important intellectual content:</italic> All authors.</p><p><italic toggle="yes">Statistical analysis:</italic> Rymer, Mulder, Wruck, Knowlton, Hammill, Jones.</p><p><italic toggle="yes">Obtained funding:</italic> Hernandez.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Rymer, Girotra, Whittle, Hess, Hammill, Harrington, Hernandez.</p><p><italic toggle="yes">Supervision:</italic> Rymer, Wruck, Mu&#241;oz, Kripalani, Benziger, Knowlton, Roe, Rothman, Harrington, Jones.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Rymer reported grants from Novo Nordisk, advisory board fees from Chiesi, and consulting fees from Abbott outside the submitted work. Dr Kripalani reported grants from Esperion and personal fees from Gilead Sciences outside the submitted work. Dr Effron reported having a pension and stock from Eli Lilly outside the submitted work. Dr Jain reported research funding from Medtronic and Boston Scientific outside the submitted work. Dr Girotra reported grants from the National Heart, Lung, and Blood Institute (R01HL160734 and R01HL166305) outside the submitted work. Dr Hess reported serving on a data and safety monitoring board (DSMB) for Astellas Pharmaceuticals outside the submitted work. Dr Benziger reported serving on a trial steering committee for Novartis outside the submitted work. Dr Knowlton reported grants from the National Institutes of Health during the conduct of the study. Dr Roe reported being an employee of AstraZeneca and receiving stock grants as part of their employment. Dr Harrington reported trial leadership and/or trial oversight funding from Janssen, CSL, Edwards, and Merck; consulting, advisory, and/or DSMB fees from Atropis, Bitterroot Bio, Bristol Myers Squibb, BridgeBio, Chiesi, Element Science, and Foresight; educational program fees from WebMD; and serving on the board of directors for Cytokinetics outside the submitted work. Dr Hernandez reported grants from AstraZeneca, Amgen, Boehringer Ingelheim, Bayer, Merck, and Novartis outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This work was supported through an award from the Patient-Centered Outcomes Research Institute (ASP-1502-27029).</p><p><bold>Role of the Funder/Sponsor:</bold> The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-HOI240040-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2024-07-24T10:00"><day>24</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2024</year></pub-date><volume>9</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">467400</issue-id><fpage>852</fpage><lpage>857</lpage><history><date date-type="received"><day>6</day><month>1</month><year>2024</year></date><date date-type="accepted"><day>16</day><month>5</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>24</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-13 00:25:19.380"><day>13</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2024 American Medical Association. All Rights Reserved.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamacardiol-e242019.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamacardiol-e242019.pdf">jamacardiol-e242019.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/cardiology/fullarticle/10.1001/jamacardio.2024.2019"/><abstract abstract-type="teaser" specific-use="electronic"><p>This analysis of a randomized clinical trial examines the clinical event data to determine which source of data (eg, electronic health records, claims, participant reports) made the greatest relative contribution to the primary end point rates.</p></abstract><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-hoi240040-1"><title>Question</title><p>Which source of data provides the greatest relative contribution for clinical end-point examination in pragmatic randomized clinical trials?</p></sec><sec id="ab-hoi240040-2"><title>Findings</title><p>In this prespecified analysis of a randomized clinical trial, most events (92%-100%) were identified in the electronic health record (EHR) or in claims data. Participant-reported data contributed less than 10% of events not otherwise available from claims or EHR data.</p></sec><sec id="ab-hoi240040-3"><title>Meaning</title><p>In a large pragmatic randomized clinical trial, claims and EHR data provided the most clinical end-point data when compared with participant-reported events.</p></sec></abstract><abstract><sec id="ab-hoi240040-4"><title>Importance</title><p>Pragmatic randomized clinical trials (RCTs) often use multiple data sources to examine clinical events, but the relative contribution of data sources to clinical end-point rates is understudied.</p></sec><sec id="ab-hoi240040-5"><title>Objective</title><p>To assess the contribution of data sources (electronic health records [EHRs], public/private insurance claims, and/or participant-reported data) to clinical end points among ADAPTABLE participants who had available data.</p></sec><sec id="ab-hoi240040-6"><title>Design, Setting, and Participants</title><p>The ADAPTABLE study was an open-label, pragmatic RCT from April 2016 through June 2019 conducted in research networks within clinical practice. Participants had existing atherosclerotic cardiovascular disease and available data to analyze. The characteristics of patients by combinations of data source availability were compared to examine the contribution of each of the data sources to end-point ascertainment. Data for this prespecified analysis were examined from January 2022 to June 2023.</p></sec><sec id="ab-hoi240040-7"><title>Exposures</title><p>Randomized exposure to 81 mg or 325 mg of aspirin daily.</p></sec><sec id="ab-hoi240040-8"><title>Main Outcomes and Measures</title><p>Number of events for the primary end point (composite of death, hospitalization for myocardial infarction, and hospitalization for stroke) that were contributed by EHR or claims data and then number of events contributed by each additional data source.</p></sec><sec id="ab-hoi240040-9"><title>Results</title><p>Of 15&#8201;006 participants randomized with at least 1 other source of data available beyond participant-reported data, there were 8756 (58.3%) with participant-reported and EHR data; 4291 (28.6%) with participant-reported, EHR, and claims data; 1412 (9.4%) with EHR-only data; 262 (1.7%) with participant-reported and claims data; 202 (1.3%) with EHR and claims data; and 83 (0.6%) with claims-only data. Participants with EHR-only data were younger (median age, 63.7 years; IQR, 55.8-71.4) compared with the other groups (range, 65.6-71.9 years). Among participants with both EHR and claims data, with or without participant-reported data (n&#8201;=&#8201;4493), for each outcome, most events (92%-100%) were identified in the EHR or in claims data. For all clinical end points, participant-reported data contributed less than 10% of events not otherwise available from claims or EHR data.</p></sec><sec id="ab-hoi240040-10"><title>Conclusions and Relevance</title><p>In this analysis of a pragmatic RCT, claims and EHR data provided the most clinical end-point data when compared with participant-reported events. These findings provide a framework for collecting end points in pragmatic clinical trials. Further work is needed to understand the data source combinations that most effectively provide clinical end-point data in RCTs.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>